Pazopanib NCRCC, Ph2 STUDY
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Pazopanib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 28 Apr 2017 Last checked against ClinicalTrials.gov record.
- 24 Apr 2017 Status changed from active, no longer recruiting to completed.